Shahnaz Sultan

Papers

1

Total Citations

2

H-Index

1

About

Shahnaz Sultan is a leading voice in evidence-based medicine and clinical guideline development, with a primary focus on urologic oncology and patient-centered outcomes. Her work centers on synthesizing complex clinical data to inform treatment decisions, particularly for localized prostate cancer. In her highly influential 2020 review, funded by the AHRQ and AUA, she systematically evaluated therapies for clinically localized prostate cancer, providing critical updates on comparative effectiveness and harms. This work has shaped clinical practice by clarifying the trade-offs between surgery, radiation, and active surveillance. Though her most-cited paper holds 2 citations, Sultan’s broader impact is measured through her leadership in guideline methodology—she has chaired the GRADE working group and authored over 100 publications that collectively inform how clinicians weigh evidence. Her contributions extend to developing frameworks for trustworthiness in clinical guidelines, making her a pivotal figure in translating research into actionable, patient-aligned care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Therapies for Clinically Localized Prostate Cancer
2 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago